Suspension of trading

Company Venus Concept Inc.

Stocks

VERO

US92332W3034

Advanced Medical Equipment & Technology

Delayed OTC Markets 20:44:37 06/04/2026 +04			5-day change	1st Jan Change
0.3105 ^USD	+2.56%		-0.00%	-79.02%

05-14	Venus Concept Inc. Announces Senior Management Changes	CI
04-09	Venus Concept Inc. announced that it has received $1.5 million in funding	CI

Business description: Venus Concept Inc.

Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Companyâ€™s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industryâ€™s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.

Number of employees: 292

Sales by Activity: Venus Concept Inc.

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Designs and Sells a Full-Suite of Aesthetic and Medical Products and Services	78.01M	106M	99.5M	76.35M	64.83M

See all business segments

Geographical breakdown of sales: Venus Concept Inc.

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
United States	33.99M	53.52M	52.1M	43.45M	38.18M
International	44.03M	52.1M	47.4M	32.9M	26.66M

See all geographic segments

Executive Committee: Venus Concept Inc.

Manager	Title	Age	Since
Rajiv de Silva CEO	Chief Executive Officer	60	02/10/2022
Domenic della Penna DFI	Director of Finance/CFO	65	01/09/2017
Anat Kotler SAM	Sales & Marketing	-	-
Melissa Kang SAM	Sales & Marketing	-	-
Sylvia Wilkinson LAW	General Counsel	-	-

See VENUS CONCEPT INC. governance

Composition of the Board of Directors: Venus Concept Inc.

Director	Title	Age	Since
Keith Sullivan BRD	Director/Board Member	67	01/07/2018
Louise Lacchin BRD	Director/Board Member	69	01/08/2015
Anthony Natale BRD	Director/Board Member	53	01/11/2019
Fritz LaPorte BRD	Director/Board Member	57	01/11/2019
R. Barry CHM	Chairman	54	01/11/2019
Rajiv de Silva BRD	Director/Board Member	60	02/10/2022
Stanley Hollmig BRD	Director/Board Member	45	01/01/2022

Composition of the Board of Directors

Company details: Venus Concept Inc.

Venus Concept, Inc.

235 Yorkland Boulevard

M2J 4Y8, Toronto

http://www.venus.ai

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VENUS CONCEPT INC.	+2.56%	-0.00%	-86.62%	-98.53%	577K
THERMO FISHER SCIENTIFIC, INC.	+4.38%	+2.22%	+23.70%	+15.81%	218B
DANAHER CORPORATION	+5.98%	+2.41%	-0.69%	-15.76%	140B
INTUITIVE SURGICAL, INC.	+3.11%	+0.35%	-15.97%	+40.47%	138B
BOSTON SCIENTIFIC CORPORATION	+3.67%	+0.43%	-50.23%	+2.42%	73.14B
EDWARDS LIFESCIENCES CORPORATION	+1.92%	-0.64%	+17.13%	+21.12%	52.44B
SIEMENS HEALTHINEERS AG	+1.20%	+1.95%	-16.55%	-12.51%	50.85B
AGILENT TECHNOLOGIES, INC.	+4.12%	+4.05%	+28.42%	+29.77%	41.92B
WATERS CORPORATION	+3.51%	+0.06%	+39.87%	+55.86%	39.42B
GE HEALTHCARE TECHNOLOGIES INC.	+3.44%	+3.59%	+1.22%	+8.56%	32.81B
Average	+3.36%	-1.67%	-5.97%	+4.72%	78.69B
Weighted average by Cap.	+3.89%	-2.40%	+2.60%	+14.24%